| Nonbiopsy diagnosis of cardiac transthyretin amyloidosis JD Gillmore, MS Maurer, RH Falk, G Merlini, T Damy, A Dispenzieri, ... Circulation 133 (24), 2404-2412, 2016 | 1968 | 2016 |
| Natural history and outcome in systemic AA amyloidosis HJ Lachmann, HJB Goodman, JA Gilbertson, JR Gallimore, CA Sabin, ... New England Journal of Medicine 356 (23), 2361-2371, 2007 | 1242 | 2007 |
| Use of canakinumab in the cryopyrin-associated periodic syndrome HJ Lachmann, I Kone-Paut, JB Kuemmerle-Deschner, KS Leslie, ... New England Journal of Medicine 360 (23), 2416-2425, 2009 | 1034 | 2009 |
| Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease DB Beck, MA Ferrada, KA Sikora, AK Ombrello, JC Collins, W Pei, ... New England Journal of Medicine 383 (27), 2628-2638, 2020 | 926 | 2020 |
| Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis HJ Lachmann, DR Booth, SE Booth, A Bybee, JA Gilbertson, JD Gillmore, ... New England Journal of Medicine 346 (23), 1786-1791, 2002 | 797 | 2002 |
| Spectrum of clinical features in Muckle‐Wells syndrome and response to anakinra PN Hawkins, HJ Lachmann, E Aganna, MF McDermott Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 692 | 2004 |
| A new staging system for cardiac transthyretin amyloidosis JD Gillmore, T Damy, M Fontana, M Hutchinson, HJ Lachmann, ... European heart journal 39 (30), 2799-2806, 2018 | 667 | 2018 |
| Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis MB Pepys, J Herbert, WL Hutchinson, GA Tennent, HJ Lachmann, ... Nature 417 (6886), 254-259, 2002 | 643 | 2002 |
| Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis M Fontana, S Pica, P Reant, A Abdel-Gadir, TA Treibel, SM Banypersad, ... Circulation 132 (16), 1570-1579, 2015 | 627 | 2015 |
| High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis A Jaccard, P Moreau, V Leblond, X Leleu, L Benboubker, O Hermine, ... New England Journal of Medicine 357 (11), 1083-1093, 2007 | 605 | 2007 |
| The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group N Leung, F Bridoux, V Batuman, A Chaidos, P Cockwell, VD D’Agati, ... Nature Reviews Nephrology 15 (1), 45-59, 2019 | 568 | 2019 |
| Interleukin-1–receptor antagonist in the Muckle–Wells syndrome PN Hawkins, HJ Lachmann, MF McDermott New England Journal of Medicine 348 (25), 2583-2584, 2003 | 566 | 2003 |
| The European Society for Immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity MG Seidel, G Kindle, B Gathmann, I Quinti, M Buckland, J van Montfrans, ... The Journal of Allergy and Clinical Immunology: In Practice 7 (6), 1763-1770, 2019 | 554 | 2019 |
| Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy HJ Lachmann, R Gallimore, JD Gillmore, HD Carr‐Smith, AR Bradwell, ... British journal of haematology 122 (1), 78-84, 2003 | 550 | 2003 |
| Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations HJ Lachmann, B Şengül, TU Yavuzşen, DR Booth, SE Booth, A Bybee, ... Rheumatology 45 (6), 746-750, 2006 | 530* | 2006 |
| T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells G Arbore, EE West, R Spolski, AAB Robertson, A Klos, C Rheinheimer, ... Science 352 (6292), aad1210, 2016 | 524 | 2016 |
| Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review N Ter Haar, H Lachmann, S Özen, P Woo, Y Uziel, C Modesto, ... Annals of the rheumatic diseases 72 (5), 678-685, 2013 | 501 | 2013 |
| Canakinumab for the treatment of autoinflammatory recurrent fever syndromes F De Benedetti, M Gattorno, J Anton, E Ben-Chetrit, J Frenkel, ... New England Journal of Medicine 378 (20), 1908-1919, 2018 | 490 | 2018 |
| Native T1 mapping in transthyretin amyloidosis M Fontana, SM Banypersad, TA Treibel, V Maestrini, DM Sado, SK White, ... JACC: Cardiovascular Imaging 7 (2), 157-165, 2014 | 476 | 2014 |
| Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis T Lane, M Fontana, A Martinez-Naharro, CC Quarta, CJ Whelan, A Petrie, ... Circulation 140 (1), 16-26, 2019 | 466 | 2019 |
Philip HawkinsProfessor of MedicineZweryfikowany adres z ucl.ac.uk
